Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total funding of 50’000 Euros.
You may also like
On 20 January 2023 the representatives of the FAIRVASC consortium had the opportunity to meet once again at a plenary session and […]
1) FAIRVASC has released a new data quality analysis lately. Can you comment on it? Major differences with respect to the previous […]
The FAIRVASC consortium warmly welcomes collaborating PI Professor Louis Aslett to the FAIRVASC team! Prof Aslett is an Associate Professor of Statistics […]
This two-day international webinar is composed of a multi-professional faculty reflecting the multi-systemic nature of vasculitis and autoinflammation. Vasculitis: From cell to […]